Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy.
about
Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsBiomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk.Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients.
P2860
Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Effect of TP53 codon 72 and MD ...... erative adjuvant chemotherapy.
@en
Effect of TP53 codon 72 and MD ...... erative adjuvant chemotherapy.
@nl
type
label
Effect of TP53 codon 72 and MD ...... erative adjuvant chemotherapy.
@en
Effect of TP53 codon 72 and MD ...... erative adjuvant chemotherapy.
@nl
prefLabel
Effect of TP53 codon 72 and MD ...... erative adjuvant chemotherapy.
@en
Effect of TP53 codon 72 and MD ...... erative adjuvant chemotherapy.
@nl
P2093
P2860
P1476
Effect of TP53 codon 72 and MD ...... erative adjuvant chemotherapy.
@en
P2093
Dongmei Wu
Jianwei Zhou
Meilin Wang
Qinghong Zhao
Shizhi Wang
Weida Gong
Zhengdong Zhang
P2860
P2888
P304
P356
10.1007/S00280-013-2103-3
P577
2013-02-20T00:00:00Z
P6179
1048061764